Protagonist Therapeutics (PTGX) Other Non-Current Assets (2015 - 2026)

Protagonist Therapeutics has disclosed Other Non-Current Assets across 12 years of filings, most recently posting $288000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $288000.0, up 28.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $288000.0 (up 28.0% YoY), and the FY2025 annual result was $287000.0, up 27.56% from the prior year.
• Other Non-Current Assets came in at $288000.0 for Q1 2026 at Protagonist Therapeutics, roughly flat from $287000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $290000.0 in Q2 2025 to a low of $225000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $225000.0 (2022), against an average of $239823.5.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and increased 28.89% in 2025, its largest moves.
• Protagonist Therapeutics' Other Non-Current Assets stood at $225000.0 in 2022, then changed by 0.0% to $225000.0 in 2023, then changed by 0.0% to $225000.0 in 2024, then advanced by 27.56% to $287000.0 in 2025, then rose by 0.35% to $288000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $288000.0 (Q1 2026), $287000.0 (Q4 2025), and $287000.0 (Q3 2025), per Business Quant data.